ES2121949T3 - Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos. - Google Patents

Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos.

Info

Publication number
ES2121949T3
ES2121949T3 ES93305090T ES93305090T ES2121949T3 ES 2121949 T3 ES2121949 T3 ES 2121949T3 ES 93305090 T ES93305090 T ES 93305090T ES 93305090 T ES93305090 T ES 93305090T ES 2121949 T3 ES2121949 T3 ES 2121949T3
Authority
ES
Spain
Prior art keywords
trioxygenates
useful
benzene derivatives
antagonists
leucotrene
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93305090T
Other languages
English (en)
Inventor
Michael Joseph Sofia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eli Lilly and Co
Original Assignee
Eli Lilly and Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eli Lilly and Co filed Critical Eli Lilly and Co
Application granted granted Critical
Publication of ES2121949T3 publication Critical patent/ES2121949T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D257/00—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02—Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04—Five-membered rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
    • C07D311/66—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pyrane Compounds (AREA)

Abstract

ESTA INVENCION PROPORCIONA DERIVADOS DE BENCENO 1,2,4 RIOXIGENADOS, QUE SON FORMULACIONES DE LEUKOTRIENE B4, ANTAGONISTAS, DE AQUELLOS DERIVADOS, Y UN METODO DE UTILIZAR TALES DERIVADOS PARA EL TRATAMIENTO DE CONDICIONES CARACTERIZADAS POR UN EXCESO DE LIBERACION DE LEUKOTRIENES.
ES93305090T 1992-07-01 1993-06-29 Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos. Expired - Lifetime ES2121949T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/907,492 US5352690A (en) 1992-07-01 1992-07-01 1,2,4-trioxygenated benzene derivatives useful as leukotriene antagonists

Publications (1)

Publication Number Publication Date
ES2121949T3 true ES2121949T3 (es) 1998-12-16

Family

ID=25424188

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93305090T Expired - Lifetime ES2121949T3 (es) 1992-07-01 1993-06-29 Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos.

Country Status (6)

Country Link
US (1) US5352690A (es)
EP (1) EP0579412B1 (es)
JP (1) JPH0680566A (es)
CA (1) CA2095487A1 (es)
DE (1) DE69321411T2 (es)
ES (1) ES2121949T3 (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5859051A (en) * 1996-02-02 1999-01-12 Merck & Co., Inc. Antidiabetic agents
US6020382A (en) * 1996-02-02 2000-02-01 Merck & Co., Inc. Method of treating diabetes and related disease states
US6090836A (en) * 1996-02-02 2000-07-18 Merck & Co., Inc. Benzisoxazole-derived antidiabetic compounds
US5847008A (en) * 1996-02-02 1998-12-08 Merck & Co., Inc. Method of treating diabetes and related disease states
US5916922A (en) * 1996-12-03 1999-06-29 Eli Lilly And Company Phenyl glyoxamides as SPLA2 inhibitors
US6090839A (en) * 1996-12-23 2000-07-18 Merck & Co., Inc. Antidiabetic agents
US6160000A (en) * 1996-12-23 2000-12-12 Merck & Co., Inc. Antidiabetic agents based on aryl and heteroarylacetic acids
JP2004513090A (ja) 2000-09-27 2004-04-30 メルク　エンド　カムパニー　インコーポレーテッド 糖尿病及び脂質異常症の治療のためのベンゾピランカルボン酸誘導体
AU2002248221B2 (en) * 2000-10-31 2006-08-17 Merck & Co., Inc. Benzopyrancarboxylic acid derivatives for the treatment of diabetes and lipid disorders
JP4475406B2 (ja) * 2002-07-30 2010-06-09 メルク・シャープ・エンド・ドーム・コーポレイション 異常脂血症および他の脂質障害の治療用のＰＰＡＲα選択的化合物
US8354427B2 (en) * 2004-06-24 2013-01-15 Vertex Pharmaceutical Incorporated Modulators of ATP-binding cassette transporters
LT2502911T (lt) 2004-06-24 2017-09-11 Vertex Pharmaceuticals Incorporated Atp surišančios kasetės transporterių moduliatoriai
CA2634113A1 (en) * 2005-12-24 2007-07-05 Vertex Pharmaceuticals Incorporated Quinolin- 4 - one derivatives as modulators of abc transporters
WO2007079139A2 (en) 2005-12-28 2007-07-12 Vertex Pharmaceuticals, Inc. Solid forms of n-[2,4-bis(1,1-dimethylethyl)-5-hydroxyphenyl]-1,4-dihydro-4-oxoquinoline-3-carboxamide
US20100074949A1 (en) 2008-08-13 2010-03-25 William Rowe Pharmaceutical composition and administration thereof
US12458635B2 (en) 2008-08-13 2025-11-04 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administrations thereof
SI2408750T1 (sl) 2009-03-20 2015-11-30 Vertex Pharmaceuticals Incorporated Postopek za izdelavo modulatorjev cistično-fibroznega transmembranskega regulatorja prevodnosti
US8802700B2 (en) 2010-12-10 2014-08-12 Vertex Pharmaceuticals Incorporated Modulators of ATP-Binding Cassette transporters
WO2013112040A1 (en) 2012-01-27 2013-08-01 Biotropics Malaysia Berhad Use of certain trioxygenated benzene derivatives in body fat management
EP2819670A1 (en) 2012-02-27 2015-01-07 Vertex Pharmaceuticals Incorporated Pharmaceutical composition and administration thereof
KR20170063954A (ko) 2014-10-07 2017-06-08 버텍스 파마슈티칼스 인코포레이티드 낭성 섬유증 막횡단 전도도 조절자의 조정제의 공-결정

Family Cites Families (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1384530A (en) * 1971-07-29 1975-02-19 Fisons Ltd Chromone derivatives
SU469247A3 (ru) * 1972-01-14 1975-04-30 Майлз Лабораториз Инк (Фирма) Способ получени производных хромона
EP0056172B1 (en) * 1981-01-09 1985-04-03 FISONS plc Phenoxy- and thiophenoxy compounds, methods for their preparation and pharmaceutical formulations containing them
EP0061800B1 (en) * 1981-03-24 1985-08-28 FISONS plc Anti srs-a carboxylic acid derivatives, processes for their production and pharmaceutical formulations containing them
US4661505A (en) * 1982-11-03 1987-04-28 Eli Lilly And Company Leukotriene antagonists
US5105017A (en) * 1983-07-18 1992-04-14 Eli Lilly And Company Leukotriene antagonist intermediates
US4665203A (en) * 1983-08-08 1987-05-12 G. D. Searle & Co. Substituted dihydrobenzopyrans useful as leukotriene D4 inhibitors
US4565882A (en) * 1984-01-06 1986-01-21 G. D. Searle & Co. Substituted dihydrobenzopyran-2-carboxylates
ZA875319B (en) * 1986-08-15 1988-02-15 F. Hoffmann-La Roche & Co. Aktiengesellschaft Use of dihydro benzopyran derivatives
US4945099A (en) * 1987-01-12 1990-07-31 Eli Lilly And Company Anti-inflammatory agents
US4889871A (en) * 1987-05-29 1989-12-26 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylate derivatives
EP0336068A1 (en) * 1988-02-11 1989-10-11 F. Hoffmann-La Roche Ag Phenoxyalkoxy-3,4-dihydro-2H-1-benzopyran derivatives
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
US5073562A (en) * 1990-05-10 1991-12-17 G. D. Searle & Co. Alkoxy-substituted dihydrobenzopyran-2-carboxylic acids and derivatives thereof

Also Published As

Publication number Publication date
JPH0680566A (ja) 1994-03-22
DE69321411D1 (de) 1998-11-12
EP0579412A1 (en) 1994-01-19
EP0579412B1 (en) 1998-10-07
US5352690A (en) 1994-10-04
DE69321411T2 (de) 1999-03-25
CA2095487A1 (en) 1994-01-02

Similar Documents

Publication Publication Date Title
ES2121949T3 (es) Derivados de benceno 1,2,4-trioxigenados utiles como antagonistas de leucotrienos.
ES2019987B3 (es) Agentes antiinflamatorios.
ES2045110T3 (es) Mejoras en o relacionadas con antagonistas de leucotrienos.
ES2191152T3 (es) Terapia combinada para el tratamiento de psicosis.
ES2190430T3 (es) Nuevas sulfonamidas.
BR9814040A (pt) Agudo no pulmão com fibrose com antagonistas de avb6
AR005987A1 (es) Terapia combinada para la osteoporosis
ES2135083T3 (es) Trifeniletilenos para la prevencion y el tratamiento de la osteoporosis.
ES2164842T3 (es) Procedimiento para la preparacion de composiciones de microcapsulas.
ES2191320T3 (es) Derivados de piperazina y su uso como agentes anti-inflamatorios.
ES2166807T3 (es) Piridazinonas y su uso como fungicidas.
ES2163407T3 (es) Derivados piperidinilos tiaciclicos.
GT199800177A (es) Combinacion eficaz para el tratamiento de la impotencia .
MX9400341A (es) Derivados de los acidos quinolon- y naftiridon-carboxilicos, procedimiento para su obtencion y agentes antibacterianos y aditivos para piensos que los contienen.
ES2195382T3 (es) Compuestos indolcarboxilicos y su uso como compuestos farmaceuticos.
PA8457001A1 (es) Derivados del 2-(4-aril o heteroaril-piperazin-i-ilmetil)-1h-indol
ES2179138T3 (es) Poliisocianatos que presentan grupos alofanato basados en difenilmetanodiisocianato con grupos isocianato predominante o completamente bloqueados.
CO4700426A1 (es) Ligandos especificos del neuropeptido y1
AR016981A2 (es) Polipeptidos sinteticos
ES2043798T3 (es) Un metodo para preparar las prostaglandinas e.
DK0874625T3 (da) Indanderivater til antipsykotiske præparater
ES2167678T3 (es) Tratamiento y profilaxis de la pancreatitis.
MX9205358A (es) Compuestos para tratar enfermedades relacionadas con leucotrieno.
ES2180895T3 (es) Agentes insecticidas y acaricidas de 1,4-diaril-2-fluoro-2-buteno.
ES2160893T3 (es) Procedimiento y compuestos intermedios para la preparacion de compuestos de fluoroolefinas plaguicidas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 579412

Country of ref document: ES